Richard Levine, MD, performed the procedure at MedStar Surgery Center at Timonium (Md.), an ASC affiliated with Medstar Union Memorial Hospital.
The implant is used to treat anterior cruciate ligament tears. Before the implant, surgeons had to surgically reconstruct a patient’s ACL. Miach Orthopaedics initiated the BEAR III study to continue to build upon the extensive base of evidence for the BEAR Implant.
The FDA granted de novo clearance for the device in December. The implant restores natural anatomy and function of the knee, is less invasive and doesn’t require surgeons to remove a tendon like reconstruction does.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
